Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Intensive Care Unit Stay after Congenital Lung Malformation Resection: Not Always a Necessary Stop.

The Journal of pediatrics·2026
Same author

Pseudarthrosis in modern instrumented pediatric cervical spine fusion.

Journal of neurosurgery. Pediatrics·2026
Same author

Postoperative Fever in Children Hospitalized After Surgery: Incidence and Risk Factors.

Hospital pediatrics·2026
Same author

Reduced thrombotic risk with recombinant factor VIIa in neonatal cardiac surgery.

JTCVS open·2026
Same author

Ebstein Anomaly Fetal Echocardiogram Parameters are Associated with Illness Severity on Admission to the Cardiac Intensive Care Unit.

Pediatric cardiology·2026
Same author

Importance of clinical practice guidelines for specialized delivery room resuscitation of newborns with prenatally diagnosed critical congenital heart disease.

Journal of perinatology : official journal of the California Perinatal Association·2026

Related Experiment Video

Updated: Jul 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K

Inpatient Resource Utilization for Hypoplastic Left Heart Syndrome from Birth Through Fontan.

Michael Kuntz1, Eleonore Valencia2, Steven Staffa3

  • 1Division of Pediatric Cardiac Anesthesia, Department of Anesthesiology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.

Pediatric Cardiology
|December 30, 2023
PubMed
Summary

The total cost for 3-stage palliation of hypoplastic left heart syndrome (HLHS) is substantial, exceeding $1.4 million. Resource utilization, including hospital days and interstage procedures, has increased in recent years.

Keywords:
ChargesFontan palliationHypoplastic left heart syndromeResource utilization

More Related Videos

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.1K
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:27

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

162

Related Experiment Videos

Last Updated: Jul 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K
Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.1K
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:27

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

162

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Health Economics

Background:

  • Hypoplastic left heart syndrome (HLHS) necessitates complex, multi-stage surgical palliation.
  • Previous analyses of resource utilization for HLHS palliation are limited.
  • Understanding current costs and resource demands is crucial for healthcare planning.

Purpose of the Study:

  • To determine the total financial charges associated with completing 3-stage palliation for HLHS.
  • To evaluate resource utilization, including hospitalizations and procedures, during the interstage period.
  • To identify trends in costs and resource use since prior studies.

Main Methods:

  • Retrospective cohort study utilizing the Pediatric Health Information System database (2016-2021).
  • Inclusion criteria: patients completing 3-stage palliation for HLHS.
  • Analysis of total charges, hospital length of stay, interstage admissions, and procedures.

Main Results:

  • Median total adjusted charges for 3-stage palliation were $1,475,800.
  • Median hospital lengths of stay were 36 days (Stage 1), 9 days (Stage 2), and 10 days (Stage 3).
  • Pulmonary artery stenosis was the most common interstage admission diagnosis; cardiac catheterization and feeding tube placement were frequent procedures.

Conclusions:

  • Total inpatient charges for 3-stage HLHS palliation are substantial and appear to have increased.
  • Gastrointestinal comorbidities and feeding optimization significantly impact resource utilization.
  • Further research into cost-effective management strategies for HLHS is warranted.